The Completed Self: An Immunological View of the Human-Microbiome Superorganism and Risk of Chronic Diseases

Entropy

Volumn 14, Issue 11, 2012, Pages 2036-2065

  Dietert, Rodney ^a   Dietert, Janice ^b  

^a Cornell University ^*  (United States)

^b Performance Plus Consulting   (United States)

Author keywords

Biosemiotics; Chronic diseases; Commensal bacteria; Developmental immunotoxicity; Inflammation; Microbiome; Mucosal tissues; Patterns of comorbidities; Sign; Superorganism

Indexed keywords

EID: 84871665083     PISSN: None     EISSN: 10994300     Source Type: Journal    
DOI: 10.3390/e14112036     Document Type: Review

References (192)

1. Lamkanfi, M.; Walle, L.V.; Kanneganti, T.D. Deregulated inflammasome signaling in disease. Immunol. Rev. 2011, 243, 163-173.
2. Cunningham, C. Microglia and neurodegeneration: The role of systemic inflammation. Glia 2012, doi: 10.1002/glia.22350.
3. Cox, C.E. Persistent systemic inflammation in chronic critical illness. Respir. Care 2012, 57, 859-864.
4. Dietert, R.R.; DeWitt, J.C.; Luebke, R.W. Reducing the Prevalence of Immune-Based Chronic Disease. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 419-440.
5. Davidson, R.M.; Seneff, S. The initial common pathway of inflammation, disease, and death. Entropy 2012, 14, 1399-1442.
6. Oller, J.W.J. The Antithesis of Entropy: Biosemiotic Communication from Genetics to Human Language with Special Emphasis on the Immune Systems. Entropy 2010, 12, 631-705.
7. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222-227.
8. Ottman, N.; Smidt, H.; de Vos, W.M.; Belzer, C. The function of our microbiota: who is out there and what do they do? Front. Cell Infect. Microbiol. 2012, 2, 104.
9. Backhed, F. Host responses to the human microbiome. Nutr. Rev. 2012, 70, S14-17.
10. Goodacre, R. Metabolomics of a superorganism. J. Nutr. 2007, 137, 259S-266S.
11. Grice, E.A.; Segre, J.A. The Human Microbiome: Our Second Genome. Annu. Rev. Genomics Hum. Genet. 2012, 13, 151-170.
12. Eberl, G. Development and evolution of RORgammat+ cells in a microbe's world. Immunol. Rev. 2012, 245,177-188.
13. Carvalho, F.A.; Aitken, J.D.; Vijay-Kumar, M.; Gewirtz, A.T. Toll-like receptor-gut microbiota interactions: perturb at your own risk! Annu. Rev. Physiol. 2012, 74, 177-198.
14. Pang, I.K.; Iwasaki, A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol. Rev. 2012, 245, 209-226.
15. Hunziker, R.D.; Wegmann, T.G. Placental immunoregulation. Crit. Rev. Immunol. 1986, 6, 245-285.
16. Gluckman, P.D.; Pinal, C.S. Maternal-placental-fetal interactions in the endocrine regulation of fetal growth: role of somatotrophic axes. Endocrine 2002, 19, 81-89.
17. Myatt, L. Placental adaptive responses and fetal programming. J. Physiol. 2006, 572, 25-30.
18. Sandovici, I.; Hoelle, K.; Angiolini, E.; Constancia, M. Placental adaptations to the maternalfetal environment: implications for fetal growth and developmental programming. Reprod. Biomed. Online 2012, 25, 68-89.
19. Martin, R.; Nauta, A.J.; Ben, A.K.; Knippels, L.M.; Knol, J.; Garssen, J. Early life: gut microbiota and immune development in infancy. Benef. Microbes 2010, 1, 367-382.
20. Dietert, R.R.; Dietert, J.M. Strategies for Protecting Your Child's Immune System; World Scienctific Publishing Company: Singapore, 2010.
21. Sykes, L.; MacIntyre, D.A.; Yap, X.J.; Teoh, T.G.; Bennett, P.R. The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012, 2012, 967629.
22. Challis, J.R.; Lockwood, C.J.; Myatt, L.; Norman, J.E.; Strauss, J.F.; Petraglia, F. Inflammation and pregnancy. Reprod. Sci. 2009, 16, 206-215.
23. Wegmann, T.G.; Lin, H.; Guilbert, L.; Mosmann, T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 1993, 14, 353-356.
24. Liu, F.; Guo, J.; Tian, T.; Wang, H.; Dong, F.; Huang, H.; Dong, M. Placental trophoblasts shifted Th1/Th2 balance toward Th2 and inhibited Th17 immunity at fetomaternal interface. APMIS 2011, 119, 597-604.
25. Doria, A.; Iaccarino, L.; Arienti, S.; Ghirardello, A.; Zampieri, S.; Rampudda, M.E.; Cutolo, M.; Tincani, A.; Todesco, S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod. Toxicol. 2006, 22, 234-241.
26. Jin, L.P.; Fan, D.X.; Zhang, T.; Guo, P.F.; Li, D.J. The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage. Am. J. Reprod. Immunol. 2011, 66, 270-278.
27. Giannubilo, S.R.; Landi, B.; Pozzi, V.; Sartini, D.; Cecati, M.; Stortoni, P.; Corradetti, A.; Saccucci, F.; Tranquilli, A.L.; Emanuelli, M. The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. Cytokine 2012, 58, 50-56.
28. Patni, S.; Flynn, P.; Wynen, L.P.; Seager, A.L.; Morgan, G.; White, J.O.; Thornton, C.A. An introduction to Toll-like receptors and their possible role in the initiation of labour. BJOG 2007, 114, 1326-1334.
29. Hamilton, S.; Oomomian, Y.; Stephen, G.; Shynlova, O.; Tower, C.L.; Garrod, A.; Lye, S.J.; Jones, R.L. Macrophages infiltrate the human and rat decidua during term and preterm labor: evidence that decidual inflammation precedes labor. Biol. Reprod. 2012, 86, 39.
30. Shynlova, O.; Lee, Y.H.; Srikhajon, K.; Lye, S. Physiologic Uterine Inflammation and Labor Onset: Integration of Endocrine and Mechanical Signals. Reprod. Sci. 2012, doi: 10.1177/1933719112446084.
31. Dietert, R.R.; Etzel, R.A.; Chen, D.; Halonen, M.; Holladay, S.D.; Jarabek, A.M.; Landreth, K.; Peden, D.B.; Pinkerton, K.; Smialowicz, R.J.; et al. Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group summary. Environ. Health Perspect. 2000, 108, 483-490.
32. Selevan, S.G.; Kimmel, C.A.; Mendola, P. Identifying critical windows of exposure for children's health. Environ. Health Perspect. 2000, 108, 451-455.
33. Makris, S.L.; Thompson, C.M.; Euling, S.Y.; Selevan, S.G.; Sonawane, B. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83, 530-546.
34. Ley, R.E.; Peterson, D.A.; Gordon, J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124, 837-848.
35. Yang, L.; Lu, X.; Nossa, C.W.; Francois, F.; Peek, R.M.; Pei, Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009, 137, 588-597.
36. Sleator, R.D. The human superorganism- of microbes and men. Med. Hypotheses 2010, 74, 214-215.
37. Zhu, B.; Wang, X.; Li, L. Human gut microbiome: the second genome of human body. Protein Cell 2010, 1, 718-725.
38. Murdoch, T.B.; Detsky, A.S. Time to Recognize Our Fellow Travellers. J. Gen. Intern. Med. 2012, doi: 10.1007/s11606-012-2105-639.
39. Eberl, G. A new vision of immunity: homeostasis of the superorganism. Mucosal. Immunol. 2010, 3, 450-460.
40. Colloada, M.C.; Cernada, M.; Bauerl, C.; Vento, M.; Perez-Martinez, G. Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes 2012, 3, 352-365.
41. Stencel-Gabriel, K.; Gabriel, I.; Wiczkowski, A.; Paul, M.; Olejek, A. Prenatal priming of cord blood T lymphocytes by microbiota in the maternal vagina. Am. J. Reprod. Immunol. 2009, 61, 246-252.
42. Fouhy, F.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C.; Cotter, P.D. Composition of the early intestinal microbiota: Knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 2012, 3, 203-220.
43. Urbaniak, C.; Burton, J.P.; Reid, G. Breast, milk and microbes: a complex relationship that does not end with lactation. Womens Health (Lond. Engl.) 2012, 8, 385-398.
44. Cabrera-Rubio, R.; Collado, M.C.; Laitinen, K.; Salminen, S.; Isolauri, E.; Mira, A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am. J. Clin. Nutr. 2012, 96, 544-551.
45. Nagata, R.; Nagano, H.; Ogishima, D.; Nakamura, Y.; Hiruma, M.; Sugita, T. Transmission of the major skin microbiota, Malassezia, from mother to neonate. Pediatr. Int. 2012, 54, 350-355.
46. Capone, K.A.; Dowd, S.E.; Stamatas, G.N.; Nikolovski, J. Diversity of the human skin microbiome early in life. J. Invest. Dermatol. 2011, 131, 2026-2032.
47. Dong, Q.; Brulc, J.M.; Iovieno, A.; Bates, B.; Garoutte, A.; Miller, D.; Revanna, K.V.; Gao, X.; Antonopoulos, D.A.; Slepak, V.Z.; et al. Diversity of bacteria at healthy human conjunctiva. Invest. Ophthalmol. Vis. Sci. 2011, 52, 5408-5413.
48. Raskind, C.H.; Sabo, B.E.; Callan, D.A.; Farrel, P.A.; Dembry, L.M.; Gallagher, P.G. Conjunctival colonization of infants hospitalized in a neonatal intensive care unit: a longitudinal analysis. Infect. Control Hosp. Epidemiol. 2004, 25, 216-220.
49. Rampersaud, R.; Randis, T.M.; Ratner, A.J. Microbiota of the upper and lower genital tract. Semin. Fetal Neonatal Med. 2012, 17, 51-57.
50. Biasucci, G.; Rubini, M.; Riboni, S.; Morelli, L.; Bessi, E.; Retetangos, C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum. Dev. 2010, 86, 13-15.
51. Malamitsi-Puchner, A.; Protonotariou, E.; Boutsikou, T.; Makrakis, E.; Sarandakou, A.; Creatsas, G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum. Dev. 2005, 81, 387-392.
52. Mulder, I.E.; Schmidt, B.; Lewis, M.; Delday, M.; Stokes, C.R.; Bailey, M.; Aminov, R.I.; Gill, B.P.; Pluske, J.R.; Mayer, C.D.; et al. Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity. PLoS One 2011, 6, e28279.
53. Reardon, S.U.N. Meeting brings attention but little action on chronic diseases. Science 2011, 333, 1561.
54. Bloom, D.E.; Cafiero, E.T.; JanÉ-Llopis, E.; Abrahams-Gessel, S.; Bloom, L.R.; Fathima, S.; Feigl, A.B.; Gaziano, T.; Mowafi, M.; Pandya, A.; et al. The Global Economic Burden of Noncommunicable Diseases; World Economic Forum: Geneva, Switzerland, 2011.
55. Theodore, K. Chronic non-communicable diseases and the economy. West Indian Med. J. 2011, 60, 392-396.
56. Thorpe, K.E.; Philyaw, M. The medicalization of chronic disease and costs. Annu. Rev. Public Health 2012, 33, 409-423.
57. Stafford, N. Switzerland needs more GPs if it is to tackle growing burden of chronic disease. BMJ 2011, 343, d7057.
58. Dans, A.; Ng, N.; Varghese, C.; Tai, E.S.; Firestone, R.; Bonita, R. The rise of chronic noncommunicable diseases in southeast Asia: time for action. Lancet 2011, 377, 680-689.
59. Parry, J. Chronic illness and disability are a hidden economic burden in Australia. Brit. Med. J. 2012, 344, e491.
60. Mayosi, B.M.; Flisher, A.J.; Lalloo, U.G.; Sitas, F.; Tollman, S.M.; Bradshaw, D. The burden of non-communicable diseases in South Africa. Lancet 2009, 374, 934-947.
61. Schmidt, M.I.; Duncan, B.B.; Azeved e Silva, G.; Menezes, A.M.; Monteiro, C.A.; Barreto, S.M.; Chor, D.; Menezes, P.R. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011, 377, 1949-1961.
62. Stuckler, D.; Basu, S.; McKee, M. Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? Brit. Med. J. 2011, 343, d5336.
63. Mayes, R.; Oliver, T.R. Chronic disease and the shifting focus of public health: is prevention still a political lightweight? J. Health Polit. Policy Law 2012, 37, 181-200.
64. Hemenway, D. Why we don't spend enough on public health. N. Engl. J. Med. 2010, 362, 1657-1658.
65. Freudenberg, N.; Olden, K. Getting serious about the prevention of chronic diseases. Prev. Chronic Dis. 2011, 8, A90.
66. Dietert, R.R. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod. Toxicol. 2011, 31, 319-326.
67. Dietert, R.R.; Luebke, R.W. Immunotoxicity, Immune Dysfunction, and Chronic Disease; Humana Press: New York, NY, USA, 2012.
68. Skakkebaek, N.E.; Rajpert-De Meyts, E.; Main, K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16, 972-978.
69. Dalgaard, M.D.; Weinhold, N.; Edsgard, D.; Silver, J.D.; Pers, T.H.; Nielsen, J.E.; Jorgensen, N.; Juul, A.; Gerds, T.A.; Giwercman, A.; Giwercman, Y.L.; et al. A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation. J. Med. Genet. 2012, 49, 58-65.
70. Balkau, B.; Eschwege, E. The metabolic syndrome. Lancet 2005, 366, 192.
71. Dietert, R.R.; Zelikoff, J.T. Pediatric Immune Dysfunction and Health Risks Following Early- Life Immune Insult. Curr. Pediat. Rev. 2009, 5, 35-51.
72. Dietert, R.R.; Zelikoff, J.T. Identifying patterns of immune-related disease: use in disease prevention and management. World J. Pediatr. 2010, 6, 111-118.
73. Dietert, R.R.; deWitt, J.C.; Germolec, D.R.; Zelikoff, J.T. Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives. Environ. Health Perspect. 2010, 118, 1091-1099.
74. Grandjean, P. Late insights into early origins of disease. Basic Clin. Pharmacol. Toxicol. 2008, 102, 94-99.
75. Wadhwa, P.D.; Buss, C.; Entringer, S.; Swanson, J.M. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin. Reprod. Med. 2009, 27, 358-368.
76. Halfon, N.; Verhoef, P.A.; Kuo, A.A. Childhood antecedents to adult cardiovascular disease. Pediatr. Rev. 2012, 33, 51-60.
77. Barker, D.J. The fetal and infant origins of adult disease. Brit. Med. J. 1990, 301, 1111.
78. Barker, D.J. The intrauterine environment and adult cardiovascular disease. Ciba Found. Symp. 1991, 156, 3-10.
79. Mu, M.; Wang, S.F.; Sheng, J.; Zhao, Y.; Li, H.Z.; Hu, C.L.; Tao, F.B. Birth weight and subsequent blood pressure: a meta-analysis. Arch. Cardiovasc. Dis. 2012, 105, 99-113.
80. Thompson, J.A.; Regnault, T.R. In utero origins of adult insulin resistance and vascular dysfunction. Semin. Reprod. Med. 2011, 29, 211-224.
81. Portha, B.; Chavey, A.; Movassat, J. Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass. Exp. Diabetes Res. 2011, 2011, 105076.
82. Leduc, L.; Levy, E.; Bouity-Voubou, M.; Delvin, E. Fetal programming of atherosclerosis: possible role of the mitochondria. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 149, 127-130.
83. White, S.L.; Perkovic, V.; Cass, A.; Chang, C.L.; Poulter, N.R.; Spector, T.; Haysom, L.; Craig, J.C.; Salmi, I.A.; Chadban, S.J.; et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am. J. Kidney Dis. 2009, 54, 248-261.
84. Kelishadi, R. Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. Open Cardiovasc. Med. J. 2010, 4, 24-29.
85. Bethell, C.D.; Kogan, M.D.; Strickland, B.B.; Schor, E.L.; Robertson, J.; Newacheck, P.W. A national and state profile of leading health problems and health care quality for US children: key insurance disparities and across-state variations. Acad. Pediatr. 2011, 11, S22-S33.
86. Rappange, D.R.; Brouwer, W.B.; Hoogenveen, R.T.; van Baal, P.H. Healthcare costs and obesity prevention: drug costs and other sector-specific consequences. Pharmacoeconomics 2009, 27, 1031-1044.
87. Asche, C.V.; Singer, M.E.; Jhaveri, M.; Chung, H.; Miller, A. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J. Manag. Care Pharm. 2010, 16, 703-712.
88. Rius, B.; Lopez-Vicario, C.; Gonzalez-Periz, A.; Moran-Salvador, E.; Garcia-Alonso, V.; Claria, J.; Titos, E. Resolution of inflammation in obesity-induced liver disease. Front. Immunol. 2012, 3, 257.
89. Despres, J.P. Abdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link? Can. J. Cardiol. 2012, doi: 10.1016/j.cjca.2012.06.004.
90. De Heredia, F.P.; Gomez-Martinez, S.; Marcos, A. Obesity, inflammation and the immune system. Proc. Nutr. Soc. 2012, 71, 332-338.
91. Angata, T.; Fujinawa, R.; Kurimoto, A.; Nakajima, K.; Kato, M.; Takamatsu, S.; Korekane, H.; Gao, C.X.; Ohtsubo, K.; Kitazume, S.; et al. Integrated approach toward the discovery of glycobiomarkers of inflammation-related diseases. Ann. N. Y. Acad. Sci. 2012, 1253, 159-169.
92. Prasad, S.; Sung, B.; Aggarwal, B.B. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev. Med. 2012, 54, S29-S37.
93. Aller, M.A.; Arias, N.; Fuentes-Julian, S.; Blazquez-Martinez, A.; Argudo, S.; Miguel, M.P.; Arias, J.L.; Arias, J. Coupling inflammation with evo-devo. Med. Hypotheses 2012, 78, 721-731.
94. Renz, H.; Autenrieth, I.B.; Brandtzaeg, P.; Cookson, W.O.; Holgate, S.; von Mutius, E.; Valenta, R.; Haller, D. Gene-environment interaction in chronic disease: a European Science Foundation Forward Look. J. Allergy Clin. Immunol. 2011, 128, S27-S49.
95. Collins, L.M.; Toulouse, A.; Connor, T.J.; Nolan, Y.M. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Neuropharmacology 2012, 62, 2154-2168.
96. Manabe, I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ. J. 2011, 75, 2739-2748.
97. Lowe, D.B.; Storkus, W.J. Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy 2011, 3, 1265-1274.
98. Sethi, G.; Shanmugam, M.K.; Ramachandran, L.; Kumar, A.P.; Tergaonkar, V. Multifaceted link between cancer and inflammation. Biosci. Rep. 2012, 32, 1-15.
99. Kalogeropoulos, A.P.; Georgiopoulou, V.V.; Butler, J. From risk factors to structural heart disease: the role of inflammation. Heart Fail. Clin. 2012, 8, 113-123.
100. Tuttolomondo, A.; di Raimondo, D.; Pecoraro, R.; Arnao, V.; Pinto, A.; Licata, G. Atherosclerosis as an Inflammatory Disease. Curr. Pharm. Des. 2012, doi: 10.1007/s00281-009-0146-7.
101. Straub, R.H. Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. J .Mol. Med. (Berl.) 2012, 90, 523-534.
102. Osborn, O.; Olefsky, J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18, 363-374.
103. Lumeng, C.N.; Liu, J.; Geletka, L.; Delaney, C.; Delproposto, J.; Desai, A.; Oatmen, K.; Martinez-Santibanez, G.; Julius, A.; Garg, S.; et al. Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J. Immunol. 2011, 187, 6208-6216.
104. Shankar, A.; Sun, L.; Klein, B.E.; Lee, K.E.; Muntner, P.; Nieto, F.J.; Tsai, M.Y.; Cruickshanks, K.J.; Schubert, C.R.; Brazy, P.C.; et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 2011, 80, 1231-1238.
105. Miyamoto, T.; Carrero, J.J.; Stenvinkel, P. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2011, 20, 662-668.
106. Lee, C.H. Resolvins as new fascinating drug candidates for inflammatory diseases. Arch. Pharm. Res. 2012, 35, 3-7.
107. Hagberg, H.; Gressens, P.; Mallard, C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann. Neurol. 2012, 71, 444-4457.
108. Imtiaz, F.; Shafique, K.; Mirza, S.S.; Ayoob, Z.; Vart, P.; Rao, S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int. Arch. Med. 2012, 5, 2.
109. Netzer, N.; Goodenbour, J.M.; David, A.; Dittmar, K.A.; Jones, R.B.; Schneider, J.R.; Boone, D.; Eves, E.M.; Rosner, M.R.; Gibbs, J.S.; et al. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature 2009, 462, 522-526.
110. Mechtcheriakova, D.; Svoboda, M.; Meshcheryakova, A.; Jensen-Jarolim, E. Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer. Cancer Immunol. Immunother. 2012, 61, 1591-1598.
111. Chiba, T.; Marusawa, H.; Ushijima, T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012, 143, 550-563.
112. Rau, T.T.; Rogler, A.; Frischauf, M.; Jung, A.; Konturek, P.C.; Dimmler, A.; Faller, G.; Sehnert, B.; El-Rifai, W.; Hartmann, A.; et al. Methylation-Dependent Activation of CDX1 through NFkappaB: A Link from Inflammation to Intestinal Metaplasia in the Human Stomach. Am. J. Pathol. 2012, 181, 487-498.
113. Nishida, N.; Goel, A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr. Genomics 2011, 12, 130-137.
114. Nilsson, E.; Larsen, G.; Manikkam, M.; Guerrero-Bosagna, C.; Savenkova, M.I.; Skinner, M.K. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS One 2012, 7, e36129.
115. Ooi, A.T.; Ram, S.; Kuo, A.; Gilbert, J.L.; Yan, W.; Pellegrini, M.; Nickerson, D.W.; Chatila, T.A.; Gomperts, B.N. Identification of an interleukin 13-induced epigenetic signature in allergic airway inflammation. Am. J. Transl. Res. 2012, 4, 219-228.
116. Yao, H.; Rahman, I. Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD. Am. J. Physiol. Lung Cell Mol. Physiol. 2012, doi:10.1152/ajplung.00175.2012.
117. Ospelt, C.; Reedquist, K.A.; Gay, S.; Tak, P.P. Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmun. Rev. 2011, 10, 519-524.
118. Dietert, R.R. Developmental immunotoxicology: focus on health risks. Chem. Res. Toxicol. 2009, 22, 17-23.
119. Luebke, R.W.; Chen, D.H.; Dietert, R.; Yang, Y.; King, M.; Luster, M.I. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health B Crit. Rev. 2006, 9, 1-26.
120. Tonk, E.C.; Verhoef, A.; Gremmer, E.R.; van Loveren, H.; Piersma, A.H. Relative sensitivity of developmental and immune parameters in juvenile versus adult male rats after exposure to di(2- ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 2012, 260, 48-57.
121. Tonk, E.C.; Verhoef, A.; de la Fonteyne, L.J.; Waalkens-Berendsen, I.D.; Wolterbeek, A.P.; van Loveren, H.; Piersma, A.H. Developmental immunotoxicity in male rats after juvenile exposure to di-n-octyltin dichloride (DOTC). Reprod. Toxicol. 2011, 32, 341-348.
122. US Environmental Protection Agency. Integrated Risk Information System (IRIS): Trichloroethylene (CASRN 79-01-6). US Environmental Protection Agency: Washington, DC, 2011. Available online: http://www.epa.gov/iris/subst/0199.htm, accessed on 24 October 2012.
123. Grandjean, P.; Poulsen, L.K.; Heilmann, C.; Steuerwald, U.; Weihe, P. Allergy and sensitization during childhood associated with prenatal and lactational exposure to marine pollutants. Environ. Health Perspect. 2010, 118, 1429-1433.
124. Hoppin, J.A.; Umbach, D.M.; London, S.J.; Henneberger, P.K.; Kullman, G.J.; Alavanja, M.C.; Sandler, D.P. Pesticides and atopic and nonatopic asthma among farm women in the Agricultural Health Study. Am. J. Respir. Crit. Care Med. 2008, 177, 11-18.
125. Dietert, R.R.; Zelikoff, J.T. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83, 547-560.
126. Dietert, R.R.; Piepenbrink, M.S. Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environ. Health Perspect. 2006, 114, 477-483.
127. Bunn, T.L.; Parsons, P.J.; Kao, E.; Dietert, R.R. Gender-based profiles of developmental immunotoxicity to lead in the rat: assessment in juveniles and adults. J. Toxicol. Environ. Health Part A 2001, 64, 223-240.
128. Leifer, C.A.; Dietert, R.R. Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease. Toxicol. Environ. Chem. 2011, 93, 1463-1485.
129. Kasten-Jolly, J.; Heo, Y.; Lawrence, D.A. Impact of developmental lead exposure on splenic factors. Toxicol. Appl. Pharmacol. 2010, 247, 105-115.
130. Hogaboam, J.P.; Moore, A.J.; Lawrence, B.P. The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicol. Sci. 2008, 102, 160-170.
131. Dietert, R.R. Misregulated Inflammation as an Outcome of Early-Life Exposure to Endocrine Disrupting Chemicals. Rev. Environ. Health 2012, 27, 117-131.
132. Dietert, R.R. Distinguishing Environmental Causes of Immune Dysfunction from Pediatric Triggers of Disease. The Open Pediatr. Med. J. 2009, 3, 38-44.
133. Deleidi, M.; Isacson, O. Viral and inflammatory triggers of neurodegenerative diseases. Sci. Transl. Med. 2012, 4, 121ps3.
134. Vassallo, M.F.; Walker, W.A. Neonatal microbial flora and disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program 2008, 61, 211-224.
135. Gravitz, L. Microbiome: The critters within. Nature 2012, 485, S12-S13.
136. Kaplan, J.L.; Shi, H.N.; Walker, W.A. The role of microbes in developmental immunologic programming. Pediatr. Res. 2011, 69, 465-472.
137. Renz, H.; Brandtzaeg, P.; Hornef, M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 2011, 12, 9-23.
138. De Palma, G.; Kamanova, J.; Cinova, J.; Olivares, M.; Drasarova, H.; Tuckova, L.; Sanz, Y. Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. J. Leukoc. Biol. 2012, doi: 10.1189/jlb.1111581.
139. Bisgaard, H.; Li, N.; Bonnelykke, K.; Chawes, B.L.; Skov, T.; Paludan-Muller, G.; Stokholm, J.; Smith, B.; Krogfelt, K.A. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 2011, 128, 646-652.
140. Shaheen, S.O.; Newson, R.B.; Smith, G.D.; Henderson, A.J. Prenatal paracetamol exposure and asthma: further evidence against confounding. Int. J. Epidemiol. 2010, 39, 790-794.
141. Jedrychowski, W.; Galas, A.; Whyatt, R.; Perera, F. The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study. Int. J. Occup. Med. Environ. Health 2006, 19, 70-76.
142. Abt, M.C.; Osborne, L.C.; Monticelli, L.A.; Doering, T.A.; Alenghat, T.; Sonnenberg, G.F.; Paley, M.A.; Antenus, M.; Williams, K.L.; Erikson, J.; et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37, 158-170.
143. Hill, D.A.; Siracusa, M.C.; Abt, M.C.; Kim, B.S.; Kobuley, D.; Kubo, M.; Kambayashi, T.; Larosa, D.F.; Renner, E.D.; Orange, J.S.; et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 2012, 18, 538-546.
144. Probst-Hensch N.; Tanner, M.; Kessler, C.; Burri, C.; Kunzli, N. Prevention-a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting. Swiss Med. Wkly. 2011, 141, w13266.
145. Sears, M.E.; Genuis, S.J. Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J. Environ. Public Health 2012, 2012, 356798.
146. Wang, L.Y.; Zhong, Y.; Wheeler, L. Direct and indirect costs of asthma in school-age children. Prev. Chronic Dis. 2005, 2, A11.
147. Szefler, S.J.; Zeiger, R.S.; Haselkorn, T.; Mink, D.R.; Kamath, T.V.; Fish, J.E.; Chipps, B.E. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann. Allergy Asthma Immunol. 2011, 107, 110-119.
148. Wang, L.; Leslie, D.L. Health care expenditures for children with autism spectrum disorders in Medicaid. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49, 1165-1171.
149. Dionne, J.M.; Lou, K.; Er, L.; Collin, K.; White, C.T. Pharmaceutical cost distribution in childhood chronic kidney disease. Pediatr. Nephrol. 2012, 27, 1531-1539.
150. Lion, M.; Gearry, R.B.; Day, A.S.; Eglinton, T. The cost of paediatric and perianal Crohn's disease in Canterbury, New Zealand. N. Z. Med. J. 2012, 125, 11-20.
151. Patel, D.A.; Holdford, D.A.; Edwards, E.; Carroll, N.V. Estimating the economic burden of foodinduced allergic reactions and anaphylaxis in the United States. J. Allergy Clin. Immunol. 2011, 128, 110-115.
152. Belay, E.D.; Holman, R.C.; Maddox, R.A.; Foster, D.A.; Schonberger, L.B. Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep. 2003, 118, 464-469.
153. Minden, K.; Niewerth, M.; Listing, J.; Biedermann, T.; Schontube, M.; Zink, A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann. Rheum. Dis. 2004, 63, 836-842.
154. Ying, A.K.; Lairson, D.R.; Giardino, A.P.; Bondy, M.L.; Zaheer, I.; Haymond, M.W.; Heptulla, R.A. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr. Diabetes 2011, 12, 177-182.
155. Schwab, C.; McGeer, P.L. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 2008, 13, 359-69.
156. Bynoe, M.S.; Viret, C. Multiple Sclerosis, Alzheimer's Disease, and Inflammation: A Hypothetical View. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 215-252.
157. Fiala, M.; Liu, P.T.; Espinosa-Jeffrey, A.; Rosenthal, M.J.; Bernard, G.; Ringman, J.M.; Sayre, J.; Zhang, L.; Zaghi, J.; Dejbakhsh, S.; et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. USA 2007, 104, 12849-12854.
158. Roponen, M.; Yerkovich, S.T.; Hollams, E.; Sly, P.D.; Holt, P.G.; Upham, J.W. Toll-like receptor 7 function is reduced in adolescents with asthma. Eur. Respir. J. 2010, 35, 64-71.
159. Lehmann, D.M.; Williams, M.A. Asthma and Respiratory Allergic Disease. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 51-101.
160. Ariel, D.; Upadhyay, D. The role and regulation of microRNAs in asthma. Curr. Opin. Allergy Clin. Immunol. 2012, 12, 49-52.
161. Yi, H.; Yu, X.; Gao, P.; Wang, Y.; Baek, S.H.; Chen, X.; Kim, H.L.; Subjeck, J.R.; Wang, X.Y. Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood 2009, 113, 5819-5828.
162. Fairweather, D. Atherosclerosis and Inflammatory Heart Disease. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA 2012; pp. 271-289.
163. Careaga, M.; Van de Water, J.; Ashwood, P. Immune Dysfunction in Autism Spectrum Disorders. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 253-269.
164. Beamer, C.A.; Seaver, B.P.; Shepherd, D.M. COPD and Other Inflammatory Diseases of the Lung: Focus on AhR Signaling. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 313-343.
165. Langereis, J.D.; Schweizer, R.C.; Lammers, J. W.; Koenderman, L.; Ulfman, L.H. A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro. BMC Pulm. Med. 2011, 11, 44.
166. Tanaka, M.; Anders, S.; Kinney, D.K. Environment, the Immune System, and Depression: An Integrative Review and Discussion of the Infection-Defense Hypothesis. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 345-385.
167. O'Brien, S.M.; Scott, L.V.; Dinan, T.G. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol. 2004, 19, 397-403.
168. Bowman, C. Food Allergies. In Immunotoxicity, Immune Dysfunction, and Chronic Disease, Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 127-149.
169. Ganeshan, K.; Neilsen, C.V.; Hadsaitong, A.; Schleimer, R.P.; Luo, X.; Bryce, P.J. Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. J. Allergy Clin. Immunol. 2009, 123, 231-238.
170. Mao, C.; Wang, S.; Xiao, Y.; Xu, J.; Jiang, Q.; Jin, M.; Jiang, X.; Guo, H.; Ning, G.; Zhang, Y. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. J. Immunol. 2011, 186, 4734-4743.
171. Kucharska, A.M.; Gorska, E.; Wasik, M.; Pyrzak, B. Decreased CD4+CD152+ T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis. Eur. J. Med. Res. 2010, 15, 72-75.
172. Bansal, A.S.; Bradley, A.S.; Bishop, K.N.; Kiani-Alikhan, S.; Ford, B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 2012, 26, 24-31.
173. Dietert, R.R.; Dietert, J.M. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME). Toxicology 2008, 247, 61-72.
174. Maes, M.; Twisk, F.N.; Kubera, M.; Ringel, K. Evidence for inflammation and activation of cellmediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-alpha, PMN-elastase, lysozyme and neopterin. J. Affect. Disord. 2012, 136, 933-939.
175. Astier, A.L. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology 2008, 124, 149-154.
176. Kimura, A.; Kishimoto, T. IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 2010, 40, 1830-1835.
177. Solomon, B.D.; Mueller, C.; Chae, W.J.; Alabanza, L.M.; Bynoe, M.S. Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2011, 108, 2040-2045.
178. Garnero, P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol. Diagn. Ther. 2008, 12, 157-170.
179. Bhattacharyya, S.; Siegel, E.R.; Achenbach, S.J.; Khosla, S.; Suva, L.J. Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. J. Bone Miner. Res. 2008, 23, 1106-1117.
180. Berg, D.; Marek, K.; Ross, G.W.; Poewe, W. Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov. Disord. 2012, 27, 656-665.
181. Blumberg, H.; Dinh, H.; Dean, C., Jr.; Trueblood, E.S.; Bailey, K.; Shows, D.; Bhagavathula, N.; Aslam, M.N.; Varani, J.; Towne, J.E.; Sims, J.E. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J. Immunol. 2010, 185, 4354-4362.
182. Pfau, J.C., Rhematoid Arthritis. In Immunotoxicity, Immune Dysfunction, and Chronic Disease; Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 171-192.
183. Kolly, L.; Busso, N.; Palmer, G.; Talabot-Ayer, D.; Chobaz, V.; So, A. Expression and function of the NALP3 inflammasome in rheumatoid synovium. Immunology 2010, 129, 178-185.
184. Shaw, P.J.; McDermott, M.F.; Kanneganti, T.D. Inflammasomes and autoimmunity. Trends Mol. Med. 2011, 17, 57-64.
185. Zaba, L.C.; Smith, G.P.; Sanchez, M.; Prystowsky, S.D. Dendritic cells in the pathogenesis of sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 2010, 42, 32-39.
186. Nordmark, G.; Eloranta, M.L.; Ronnblom, L. Primary Sjogren's Syndrome and the Type I Interferon System. Curr. Pharm. Biotechnol. 2012, 13, 2054-2062.
187. Norheim, K.B.; Jonsson, G.; Harboe, E.; Hanasand, M.; Goransson, L.; Omdal, R. Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren's syndrome. Free Radic. Res. 2012, 46, 141-146.
188. Thomas, K.S.; Motivala, S.; Olmstead, R.; Irwin, M.R. Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav. Immun. 2011, 25, 53-58.
189. Castro, S.V.; Jimenez, S.A. Biomarkers in systemic sclerosis. Biomark. Med. 2010, 4, 133-147.
190. Luo, Y.; Zhao, M.; Lu, Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 2010, 35, 425-430.
191. Jiang, H.; Xiao, R.; Lian, X.; Kanekura, T.; Luo, Y.; Yin, Y.; Zhang, G.; Yang, Y.; Wang, Y.; Zhao, M.; et al. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin. Immunol. 2012, 143, 39-44.
192. Cooke, A.; Zacone, P. Factors Involved in Onset of Type 1 Diabetes. In Immunotoxicity, Immune Dysfunction, and Chronic Disease, Dietert, R.R., Luebke, R.W., Eds.; Humana: New York, NY, USA, 2012; pp. 153-170.